Avadel pharmaceuticals issues statement on patent litigation

Dublin, ireland, march 04, 2024 (globe newswire) -- avadel pharmaceuticals plc (nasdaq: avdl), today issued a statement in response to a jury ruling from the united states district court for the district of delaware (“court”) in a patent suit brought by jazz pharmaceuticals inc. regarding lumryz™.
AVDL Ratings Summary
AVDL Quant Ranking